Ignite Creation Date:
2024-05-06 @ 8:25 AM
Last Modification Date:
2024-10-26 @ 12:00 PM
Study NCT ID:
NCT02735850
Status:
WITHDRAWN
Last Update Posted:
2017-05-23
First Post:
2016-03-22
Brief Title:
Combination of SABR and L19-IL2 in Patients With Stage IV Lung Cancer ImmunoSABR
Sponsor:
Maastricht Radiation Oncology
Organization:
Maastricht Radiation Oncology
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-06
Completion Date Type:
ESTIMATED
First Submit Date:
2016-03-22
First Submit QC Date:
April 11 2016
Study First Post Date:
2016-04-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-22
Last Update Post Date:
2017-05-23
Last Update Post Date Type:
ACTUAL